Bio-Rad Laboratories, Inc.
| Security | BIO / Bio-Rad Laboratories, Inc. |
| Insider | Schwartz Allison |
This page shows the track record and history of Allison Schwartz
insider trades in Bio-Rad Laboratories, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Schwartz Allison in BIO / Bio-Rad Laboratories, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Schwartz Allison in BIO / Bio-Rad Laboratories, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-06 | 4 | Allison Schwartz | BIO BIO.B | Bio-Rad A Common Stock | D | 295.4300 | -33 | -10 | 1,456 | ||||
| 2025-09-09 | 2025-09-06 | 4 | Allison Schwartz | BIO BIO.B | Bio-Rad A Common Stock | D | 92 | 1,489 | ||||||
| 2025-09-03 | 2025-09-01 | 4 | Allison Schwartz | BIO BIO.B | Bio-Rad A Common Stock | D | 297.8800 | -55 | -16 | 1,397 | ||||
| 2025-09-03 | 2025-09-01 | 4 | Allison Schwartz | BIO BIO.B | Bio-Rad A Common Stock | D | 147 | 1,452 | ||||||
| 2024-09-04 | 2024-09-03 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 334.3100 | -27 | -9 | 1,305 | ||||
| 2024-09-04 | 2024-09-03 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 56 | 1,332 | ||||||
| 2024-09-04 | 2024-09-02 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -21 | -7 | 1,276 | ||||
| 2024-09-04 | 2024-09-02 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 44 | 1,297 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -15 | -5 | 1,253 | ||||
| 2024-09-04 | 2024-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 31 | 1,268 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -20 | -7 | 1,237 | ||||
| 2024-09-04 | 2024-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 42 | 1,257 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -35 | -12 | 1,215 | ||||
| 2024-09-04 | 2024-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 74 | 1,250 | ||||||
| 2024-08-28 | 2024-08-26 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad B Common Stock | D | 57 | 3,996 | ||||||
| 2023-12-08 | 2023-12-05 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad B Common Stock | D | 49 | 3,939 | ||||||
| 2023-09-06 | 2023-09-04 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -34 | -13 | 1,176 | ||||
| 2023-09-06 | 2023-09-04 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 82 | 1,210 | ||||||
| 2023-09-06 | 2023-09-03 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -23 | -9 | 1,128 | ||||
| 2023-09-06 | 2023-09-03 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 56 | 1,151 | ||||||
| 2023-09-06 | 2023-09-02 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -18 | -7 | 1,095 | ||||
| 2023-09-06 | 2023-09-02 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 44 | 1,113 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -12 | -5 | 1,069 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 30 | 1,081 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 394.6000 | -17 | -7 | 1,051 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 41 | 1,068 | ||||||
| 2022-11-28 | 2022-11-07 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad B Common Stock | D | 42 | 3,890 | ||||||
| 2022-09-07 | 2022-09-05 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 478.3200 | -33 | -16 | 1,027 | ||||
| 2022-09-07 | 2022-09-05 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 80 | 1,060 | ||||||
| 2022-09-07 | 2022-09-04 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 478.3200 | -34 | -16 | 980 | ||||
| 2022-09-07 | 2022-09-04 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 82 | 1,014 | ||||||
| 2022-09-07 | 2022-09-03 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 478.3200 | -23 | -11 | 932 | ||||
| 2022-09-07 | 2022-09-03 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 56 | 955 | ||||||
| 2022-09-07 | 2022-09-02 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 478.3200 | -18 | -9 | 899 | ||||
| 2022-09-07 | 2022-09-02 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 43 | 917 | ||||||
| 2022-09-06 | 2022-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 486.2500 | -12 | -6 | 874 | ||||
| 2022-09-06 | 2022-09-01 | 4 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 30 | 886 | ||||||
| 2022-04-28 | 3 | Allison Schwartz | BIO BIOB | Bio-Rad A Common Stock | D | 856 | ||||||||
| 2022-04-28 | 3 | Allison Schwartz | BIO BIOB | Bio-Rad B Common Stock | D | 3,848 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
